Lung Cancer Clinical Trials

Find Lung Cancer Clinical Trials Near You

A Pragmatic Randomized-Controlled Learning Health System Trial

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

To evaluate the real-world effectiveness and implementation strategies for mPATH-Lung, investigators propose a pragmatic, randomized controlled trial across an academic Learning Health System. The trial will contrast several approaches to participant outreach and will specifically target engaging fully powered cohorts of racial/ethnic minorities and rural residents.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 77
Healthy Volunteers: f
View:

⁃ Eligible patients will:

• Meet the Medicare criteria for lung cancer screening, as updated in February 2022:

• Age 50 - 77 years

• Smoked at least 20 pack years

• Current smoker or quit smoking within the past 15 years

• Be established with a primary care provider within the Atrium Health Wake Forest Baptist health network (defined as having completed at least 1 primary care appointment in the past 6 months or have completed at least 2 primary care appointments within the past 18 months or being scheduled to see a health network primary care provider within the next 30 days).

• Have a patient portal account or cellphone number listed in the electronic health record

• Have a North Carolina address listed in the electronic health record

Locations
United States
North Carolina
Atrium Health Wake Forest Baptist
RECRUITING
Winston-salem
Contact Information
Primary
Study Coordinator
Aliza.randazzo@advocatehealth.org
704-355-2000
Time Frame
Start Date: 2026-03-25
Estimated Completion Date: 2027-01
Participants
Target number of participants: 27000
Treatments
Experimental: Arm A
Patient portal message first followed by up to 3 reminder text messages.
Experimental: Arm B
Text message only with up to 3 reminder text messages.
Experimental: Arm C
Portal message only with no reminder messages.
Active_comparator: Usual Care Arm
Patients receive usual care.
Related Therapeutic Areas
Sponsors
Leads: Wake Forest University Health Sciences
Collaborators: National Cancer Institute (NCI)

This content was sourced from clinicaltrials.gov